English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Lipids 2017 Update of ESC/EAS Task Force on practical clinical guidance for proprotein convertase subtilisin/kexin type 9 inhibition in patients with atherosclerotic cardiovascular disease or in familial hypercholesterolaemia U. Landmesser, M.J. Chapman, J.K. Stock, P. Amarenco, J.J.F. Belch, J. Borén, M. Farnier, B.A. Ference, S. Gielen, I. Graham, D.E. Grobbee, G.K. Hovingh, T.F. Lüscher, M.F. Piepoli, K.K. Ray, E.S. Stroes, O. Wiklund, S. Windecker, J.L. Zamorano, F. Pinto, L. Tokgözo glu, J.J. Bax, and A.L. Catapano 1131

Lipids and lipid lowering: current management with statins and PCSK9 inhibitors